Melanoma treatment delays associated with increased mortality
Source: Healio, July 2022
Delays in melanoma treatment are associated with overall and melanoma-specific mortality, according to a study.
“The incidence of melanoma continues to rise in older individuals, with an estimated 100,350 new cases and 6,850 new deaths in 2020,” David D. Xiong, MD, of the University of Pittsburgh Medical Center, and colleagues wrote. “Prior studies have demonstrated varying effects of treatment delays on survival outcomes.”
Researchers conducted a population-based study that included 108,689 patients diagnosed with invasive melanoma in the Surveillance, Epidemiology and End Results (SEER) program of the National Cancer Institute between 2010 and 2016.